PD-1 Axis Inhibition in EGFR Positives: A Blunt Sword?
J Thorac Oncol
.
2017 Feb;12(2):171-172.
doi: 10.1016/j.jtho.2016.12.013.
Authors
David F Heigener
1
,
Martin Reck
2
Affiliations
1
Department of Thoracic Oncology, Lung Clinic Grosshansdorf, Grosshansdorf, Germany.
2
Department of Thoracic Oncology, Lung Clinic Grosshansdorf, Grosshansdorf, Germany. Electronic address: dr.martin.reck@web.de.
PMID:
28115107
DOI:
10.1016/j.jtho.2016.12.013
No abstract available
Publication types
Editorial
Comment
MeSH terms
Carcinoma, Non-Small-Cell Lung*
ErbB Receptors
Humans
Lung Neoplasms*
Substances
ErbB Receptors